ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BARRY MARTIN M.D.

11005 RALSTON RD SUITE G 100

Arvada | Colorado | 80004

(303) 431-0844

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,611Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 16

$444K Total Retail Price of All Prescriptions

Rank: 2 out of 16

361 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 1,900 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 720 72 1 1
LISINOPRIL 432 142 2 2
POLYETHYLENE GLYCOL 3350 380 35 3 18
ALENDRONATE SODIUM 331 48 4 14
OMEPRAZOLE 310 72 5 7
ATORVASTATIN CALCIUM 268 69 6 13
FLUTICASONE PROPIONATE 249 27 7 16
METFORMIN HCL 236 35 8 6
RANITIDINE HCL 189 24 9 17
CHLORHEXIDINE GLUCONATE 185 26 10 33
HYDROCHLOROTHIAZIDE 181 67 11 9
GEMFIBROZIL 165 12 12 39
AMLODIPINE BESYLATE 152 49 13 4
HYDROCODONE-ACETAMINOPHEN 149 65 S3 14 3
LIPITOR 145 46 15 44
BACLOFEN 143 0 16 45
SIMVASTATIN 139 39 17 5
WARFARIN SODIUM 137 0 18 12
ATENOLOL 132 60 19 19
FUROSEMIDE 114 46 20 8
OXYBUTYNIN CHLORIDE 104 0 21 55
FINASTERIDE 96 12 22 38
OXYBUTYNIN CHLORIDE ER 95 21 23 58
CARBAMAZEPINE 91 14 24 62
LACTULOSE 86 0 25 63
TAMSULOSIN HCL 83 12 26 22
NEXIUM 76 16 27 26
DOXAZOSIN MESYLATE 73 26 28 72
PRAVASTATIN SODIUM 72 0 29 25
HYDROXYZINE HCL 69 0 R 30 76
METOPROLOL TARTRATE 68 49 31 15
CITALOPRAM HBR 66 0 32 29
FOSINOPRIL SODIUM 64 13 33 80
ADVAIR DISKUS 63 28 34 30
RISPERIDONE 61 0 35 36
MORPHINE SULFATE ER 60 0 S2 36 46
GABAPENTIN 60 13 36 10
PANTOPRAZOLE SODIUM 58 13 38 83
TRANSDERM-SCOP 58 0 38 83
LOVASTATIN 54 0 40 32
ZOLPIDEM TARTRATE 54 32 40 27
LEVETIRACETAM 53 0 42 92
LOVAZA 51 12 43 99
KETOCONAZOLE 51 0 43 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.